Netherlands Bariatric Surgery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Netherlands Bariatric Surgery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Netherlands bariatric surgery market is poised to grow at a CAGR of 7.5% over the forecast period.

COVID-19 has impacted the growth of the bariatric surgery market in the country. Due to the lockdown measures taken by the government, the surgical centers and clinics were shut down to avoid contact and the spread of coronavirus among the population. Also, bariatric surgeries were considered to be non-emergent procedures. As a result, these procedures were on hold, and their success rate declined. For instance, as per an article published in the British Journal of Surgery, in September 2022, around 12,154 (30.2%) total patients were treated surgically in 2020. In addition, as per the same source, 1,543 patients underwent a bariatric procedure in 2020, which was lower than the previous year. Thus, the lower number of bariatric surgeries performed in the country has impacted the market's growth during the COVID-19 pandemic. However, with released restrictions, resumed surgical procedures, and increased patient visits to hospitals and centers, the market is expected to grow over the forecast period.

Certain factors propelling the market growth are the increasing number of obese patients and the growing burden of chronic diseases like cardiovascular diseases and diabetes.

The rising prevalence of chronic diseases, such as diabetes and heart disease, among the population in the country is also contributing to market growth. People with more fat in their bodies are more likely to be affected by diabetes. Hence, patients are taking specific measures to prevent obesity with bariatric surgeries. For instance, according to the 2022 statistics published by the IDF, in the Netherlands, 0.8 million people were living with diabetes in 2021. In addition, as per the same source, this number is projected to reach 0.91 million by 2030. Thus, it is anticipated that the rising number of people with diabetes, who are at a high risk of becoming overweight and developing obesity, is likely to raise the demand for bariatric surgery, driving the market's expansion.

Additionally, the growing burden of obesity among the Dutch population is the key factor driving the market growth. Obesity and overweight were formerly thought to be a concern, mainly in high-income countries. However, these are rapidly spreading to low- and middle-income countries, especially in metropolitan areas. For instance, as per 2022 statistics published by World Obesity, it has been found that 15.7% of women, 14.7% of men, and 14.2% of adults were obese in the Netherlands in 2020. As a result, the rise in the number of obese people is anticipated to raise the demand for bariatric surgery, which is expected to fuel market expansion.

Therefore, owing to the aforementioned factors, the studied market is expected to increase over the forecast period. However, the high cost of surgery is likely to hinder the market growth over the forecast period.

A gastric balloon, also referred to as an intragastric balloon (IGB) or a stomach balloon, is an inflatable medical tool that is momentarily inserted into the stomach to aid in weight loss. Usually, by an endoscope, the soft saline solution or an air-filled balloon is inserted into the stomach. Due to its space-occupying design, the balloon acts as a limiting mechanism and encourages the sensation of satiety.

The introduction of new products, increased patient awareness, collaboration with bariatric surgery centers, and manufacturing optimization to increase operating leverage are some factors driving the demand for balloons.

According to an article published in the Obesity Science and Practice journal in April 2021, bariatric surgery is the most effective intervention strategy that helps patients lose weight permanently and reduces comorbidities. In addition, preoperative intragastric balloon surgery significantly decreased liver volume in individuals with super obesity, shortened the surgical procedure, and reduced the chance of serious adverse events.

Furthermore, various companies are providing bariatric surgery, which is also expected to fuel the segment's growth. For instance, Allurion Kliniek is specialized in the Elipse Gastric Balloon, the first solution for weight loss without surgery, endoscopy, and anesthesia. The total cost for the Elipse gastric balloon program is EUR 4.195, including medical intake, the Elipse gastric balloon placement, a lifestyle program with personal support from a lifestyle coach for nutrition and exercise advice, an Allurion Bluetooth scale, and an Allurion smartphone app.

Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.

The stapling devices market is expected to witness healthy growth in the bariatric surgery devices market in the Netherlands due to the rising number of bariatric surgeries, the high prevalence of the obese population, and other factors. In addition, the rising burden of type 2 diabetes among the population increases the demand for bariatric surgery, which helps control the sugar level in the blood. This is also anticipated to fuel the demand for stapler devices, propelling the market growth.

Stapling devices remove a part of an organ, cut through and seal organs and tissues, and create connections between structures. Thus, most bariatric procedures are currently being performed with mechanical stapling devices, thereby contributing to the overall growth. It is one of the most prominent devices as it frequently leads to more significant and reliable weight loss surgical outcomes for patients and a more significant reduction in obesity-related health problems.

Furthermore, several clinical trials in France focus on bariatric surgeries. For instance, in July 2022, Ziekenhuisgroep Twente was analyzing significant weight reduction in patients five years after surgery who underwent a mini gastric bypass (MGB-OAGB) with the addition of the implantation of a MiniMizer Ring in the Netherlands. Thus, such studies and instances focusing on bariatric surgeries are expected to create opportunities for bariatric surgery devices available in the country, fuelling segment growth.

Hence, factors such as the high application of staplers and increasing research studies are propelling the segment's growth, and it is expected to continue its strong hold over the analysis period.

The Netherlands' bariatric surgery is moderately competitive with the presence of key market players. Some of the players in the market are Nordic Gastric Balloon, Medtronic PLC, Johnson and Johnson, Apollo Endosurgery Inc., Aspire Bariatrics, Intuitive Surgical Inc., Olympus Corporation, ReShape Lifescience Inc., and Allurion Technologies Inc., among others.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support